FDA Authorises Use of New 5-Minute Coronavirus Diagnostics Amid Ongoing Pandemic

A medical equipment and health care company, Abbott, claims that its new method will be capable of delivering as many as 50,000 tests per day and some 5 million tests per month.

Abbott announced on Friday that it had received authorisation from the US Food and Drug Administration (FDA) for a new test that allegedly takes “as little as five minutes” to detect the novel coronavirus disease (COVID-19).

The company claimed in a Friday press release that its new test is “the fastest available molecular point-of-care test” taking only five minutes to deliver a positive result and 13 minutes to deliver a negative result.

According to the company’s statement, the new method will be capable of delivering some 50,000 tests per day and around 5 million tests per month.

The company said it planned to start deploying its point-of-care ID NOW testing platforms to coronavirus hotspots in the country by next week.

The news comes as the United States has become the world’s most-affected country in the pandemic, with over 104,000 cases along with at least 1,500 deaths.

Sourse: sputniknews.com

FDA Authorises Use of New 5-Minute Coronavirus Diagnostics Amid Ongoing Pandemic

0.00 (0%) 0 votes

LEAVE A REPLY

Please enter your comment!
Please enter your name here